So as to foster further coordination, the Commission should ensure necessary consultation of Member States in advance of their participation in international fora where such strategic stocks may be discussed, in particular via the dedicated standing subgroup of the Board. Similarly, in order to increase complementarity between this Regulation and other horizontal or subject-specific instruments, the Commission should ensure that the gathered and aggregated information are passed to vigilance or crisis governance mechanisms, such as the proposed single market emergency instrument’s advisory group, the European Semiconductor Board established by Regulation (EU) 2023/1781 of the European Parliament and of the Council [Regulation (EU) 2023/1781 of the European Parliament and of the Council of 13 September 2023 establishing a framework of measures for strengthening Europe’s semiconductor ecosystem and amending Regulation (EU) 2021/694 (Chips Act) (OJ L 229, 18.9.2023, p. 1).], the HERA Board established by Commission Decision 2021/C 393 I/02 [Commission Decision 2021/C 393 I/02 of 16 September 2021 establishing the Health Emergency Preparedness and Response Authority (OJ C 393 I, 29.9.2021, p. 3).] or the Health Crisis Board established under Council Regulation (EU) 2022/2372 [Council Regulation (EU) 2022/2372 of 24 October 2022 on a framework of measures for ensuring the supply of crisis-relevant medical countermeasures in the event of a public health emergency at Union level (OJ L 314, 6.12.2022, p. 64).].
Recital 47, Regulation (EU) 2024/1252
In forcesince 11 Apr 2024